Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 756.40 INR
Change Today 0.00 / 0.00%
Volume 0.0
As of 7:05 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

aurobindo pharma ltd (ARBP) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/20/15 - 832.50
52 Week Low
09/24/14 - 381.50
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for AUROBINDO PHARMA LTD (ARBP)

Related News

No related news articles were found.

aurobindo pharma ltd (ARBP) Related Businessweek News

No Related Businessweek News Found

aurobindo pharma ltd (ARBP) Details

Aurobindo Pharma Limited engages in the development, manufacture, marketing, and distribution of generic pharmaceuticals and active pharmaceutical ingredients. The company offers generic products in the therapeutic areas of central nervous system, gastro-intestinal, cardiovascular/anti-diabetics, anti-retro virals, anti-allergics, antibiotics, carbapenams, ophthalmics, and oral contraceptives, as well as NSAIDS, anti-fungals, anti-emetics, and anti-virals. It has operations in India, the United States, Europe, and internationally. The company exports its products to approximately 125 countries worldwide. Aurobindo Pharma Limited was founded in 1986 and is headquartered in Hyderabad, India.

Founded in 1986

aurobindo pharma ltd (ARBP) Top Compensated Officers

Managing Director, Director and Member of Ris...
Total Annual Compensation: 15.9M
Whole Time Director, Member of Corporate Soci...
Total Annual Compensation: 9.0M
Vice Chairman, Chairman of Corporate Social R...
Total Annual Compensation: 9.0M
Whole Time Director and Member of Stakeholder...
Total Annual Compensation: 9.0M
Compensation as of Fiscal Year 2015.

aurobindo pharma ltd (ARBP) Key Developments

Aurobindo Pharma Limited Approves First, Second and Third Interim Dividend for the Year 2014-2015

Aurobindo Pharma Limited announced that it has approved the first interim dividend of INR 1.50, second interim dividend of INR 2.00 and third interim dividend of INR 1.00, in aggregate of INR 4.50 per equity share of INR 1.00 each, as dividend for the year 2014-2015 at its annual general meeting held on August 27, 2015.

Aurobindo Pharma Receives USFDA Approval for Entecavir Tablets

Aurobindo Pharma Limited announced that the company has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Entecavir Tablets, 0.5mg and 1mg (ANDA 206217). The approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Baraclude® Tablets, 0.5mg and 1mg, of Bristol-Myers Squibb. Entecavir Tablets are indicated for treatment of chronic hepatitis B virus infection of the liver. The product has an estimated market size of USD 294 Million for the twelve months ending June 2015 according to IMS.

Sanjeev Dani Joins Aurobindo Pharma as COO

Aurobindo Pharma announced that the company has appointed Sanjeev Dani, former senior executive with Ranbaxy Laboratories, as chief operating officer and head of formulation business. Dani, who quit Ranbaxy in 2014, will lead the front-end operations of emerging markets and Europe. He has replaced Arvind Vasudeva, who was in this role since November 2012.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARBP:IN 756.40 INR 0.00

ARBP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $38.75 USD +0.16
Biocon Ltd 441.60 INR 0.00
Cipla Ltd/India 659.85 INR 0.00
Dr Reddy's Laboratories Ltd 4,181 INR 0.00
Shasun Pharmaceuticals Ltd 363.85 INR 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation ARBP Industry Range
Price/Earnings 26.7x
Price/Sales 3.4x
Price/Book 8.3x
Price/Cash Flow 22.1x
TEV/Sales 3.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AUROBINDO PHARMA LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at